Analyst Price Target is $26.17
▲ +36.64% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Sotera Health in the last 3 months. The average price target is $26.17, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 36.64% upside from the last price of $19.15.
Current Consensus is
The current consensus among 6 investment analysts is to buy stock in Sotera Health.
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.